Clinical trials: CYP3A4 Induction
CYP3A4 Induction
Cholesterol Metabolites as Markers for CYP3A Induction
The objectives of this study are: To investigate if the endogenous cholesterol metabolite, 4beta-OHcholesterol could be used as a marker for induction of cytochrome P450 (CYP) 3A4.
- Trial name
- NCT01340456
- Testing
- Rifampicin treatment
- Where
- Sweden
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Karolinska University Hospital